🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Lurbinectedin is mainly eliminated by the liver. Thus, Hepatic Impairment (...
Status
Unknown
Location
Hospital Universitario Virgen de la Victoria
Start Date
2021-03-09
Trial ID
NCT05101265
Treatments Being Tested
Study GO43104 is a Phase III, randomized, open-label, multicenter study of ...
Status
Active Not Recruiting
Location
Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital
Start Date
2021-11-18
Trial ID
NCT05091567
Treatments Being Tested
Lung cancer is by far the leading cause of cancer death among both men and ...
Status
Recruiting
Location
Dartmouth Hitchcock Medical Center
Start Date
2022-10-12
Trial ID
NCT05578326
Treatments Being Tested
The purpose of this study is to find out if a drug called lurbinectedin (th...
Status
Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2023-07-27
Trial ID
NCT05918640
Treatments Being Tested
To learn if adding lurbinectedin to the combination of paclitaxel and bevac...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-07-12
Trial ID
NCT05636111
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of lurbine...
Status
Recruiting
Location
Valkyrie Clinical Trials, Inc.
Start Date
2026-08-30
Trial ID
NCT07459634
Treatments Being Tested
The purpose of this research is to evaluate the activity and safety of lurb...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2022-06-14
Trial ID
NCT05229588
Treatments Being Tested
Multicenter, open-label, randomized, controlled phase III clinical trial to...
Status
Completed
Location
Ironwood Cancer & Research Centers
Start Date
2022-07-22
Trial ID
NCT05153239
Treatments Being Tested
Prospective, open-label, two-way crossover, phase Ib drug-drug interaction ...
Status
Completed
Location
Fundacion Jimenez Diaz
Start Date
2020-10-07
Trial ID
NCT05063318
Treatments Being Tested
The main objective is to compare the efficacy of tarlatamab with standard o...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2023-05-31
Trial ID
NCT05740566
Treatments Being Tested